中科微点-全球专利检索

  1. Login
  2. Sign Up
Invention Grant
US08524246B2 Treatment of immune disease by mucosal delivery of antigents using genetically modified Lactobacillus 有权
使用遗传修饰的乳球菌治疗免疫疾病通过粘膜递送前列腺素

  • Patent Title: Treatment of immune disease by mucosal delivery of antigents using genetically modified Lactobacillus
  • Patent Title (中): 使用遗传修饰的乳球菌治疗免疫疾病通过粘膜递送前列腺素
  • Application No.: US13720967
    Application Date: 2012-12-19
  • Publication No.: US08524246B2
    Publication Date: 2013-09-03
  • Inventor: Pieter Rottiers , Veerle Snoeck
  • Applicant: Actogenix NV
  • Applicant Address: BE Zwijnaarde
  • Assignee: Actogenix N.V.
  • Current Assignee: Actogenix N.V.
  • Current Assignee Address: BE Zwijnaarde
  • Agency: TraskBritt
  • Priority: EP07447006 20070125; EP07112792 20070719; EPPCT/EP2008/050900 20080125
  • Main IPC: A61K39/02
  • IPC: A61K39/02 ;  A61K39/00 ;  A61K38/00 ;  A01N63/00
Treatment of immune disease by mucosal delivery of antigents using genetically modified Lactobacillus
Abstract:
The present invention relates to the treatment of autoimmune and allergic diseases by mucosal delivery by micro-organism, in particular Lactococcus lactis, of secreted immunodominant antigens.
Abstract(Chinese):

本发明涉及通过分泌免疫显性抗原的微生物特别是乳酸乳球菌的粘膜递送来治疗自身免疫性和过敏性疾病。

Public/Granted literature
Information query
Espacenet
Patent Agency Ranking
0/0